Hunniwell Lake Ventures

Hunniwell Lake Ventures is a venture capital investment firm established in 2019 and located in Palo Alto, California. The firm specializes in investing in the healthcare and medical device sectors, focusing on extensions of proven technologies in overlooked market segments. By providing entrepreneurs with a longer development timeline, Hunniwell Lake Ventures enables them to build a more comprehensive portfolio of products before monetization. The firm leverages its entrepreneurial spirit, operational expertise, and extensive global networks to enhance the profitability of its portfolio companies through improved market access, greater capital efficiency in research and development, and reduced manufacturing costs.

Richard Fang

Managing Partner and Founder

Daniel Teo

Managing Partner and Founder

2 past transactions

WaveClear

Series A in 2020
WaveClear Inc. is a medical device company based in Erie, Pennsylvania, established in 2020. The company focuses on the design and development of ultrasonic therapeutic devices specifically aimed at treating vascular diseases. Utilizing advanced ultrasonic technology, WaveClear aims to address occlusions within the peripheral vasculature, offering innovative solutions for healthcare providers and patients suffering from vascular conditions.

CoapTech

Series B in 2020
CoapTech is an early-stage medical device company based in Baltimore, Maryland, founded in 2016 by Dr. Tropello. The company specializes in researching and manufacturing ultrasound-based solutions for feeding tube placement. Its flagship product, the Point-of-care Ultrasound Magnet Aligned (PUMA-G) System, utilizes a patent-pending technology called Coaptive Ultrasound to enhance safety and reduce healthcare costs. This system employs strong rare-earth magnets for device guidance and real-time, low-cost ultrasound for visual feedback, enabling non-surgical providers to perform procedures such as Percutaneous Ultrasound Gastrostomy (PUG). By eliminating risks associated with traditional methods like organ damage, infections, or cancer from fluoroscopy, CoapTech aims to improve medical care delivery globally.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.